The antihypertensive agent cicletanine reverses vascular hyperreactivity to noradrenaline and cardiac hypertrophy in DOCA-salt rats

Arch Int Pharmacodyn Ther. 1990 Sep-Oct:307:109-18.

Abstract

Cicletanine, when given p.o. either acutely or subchronically, was found to produce a clear-cut antihypertensive effect in the deoxycorticosterone salt experimental rat model. This compound was able to reverse high blood pressure, even at doses deprived of diuretic effect. Subchronic treatment (30 mg/kg, p.o.; 14 days) with cicletanine reduced the enhanced contractile response to noradrenaline in deoxycorticosterone salt rat aortic strips and reversed the cardiac hypertrophy in these animals. The antihypertensive effect after long-term treatment with cicletanine in deoxycorticosterone salt rats appears to be related to an antagonism of the elevated sympathetic drive to the vascular smooth muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenalectomy
  • Animals
  • Antihypertensive Agents*
  • Aorta, Thoracic / drug effects
  • Blood Pressure / drug effects
  • Blood Vessels / physiopathology*
  • Cardiomegaly / drug therapy*
  • Cardiomegaly / etiology
  • Desoxycorticosterone
  • Diuresis / drug effects
  • Diuretics / pharmacology*
  • Heart Rate / drug effects
  • Hypertension / chemically induced
  • Hypertension / complications
  • Hypertension / physiopathology*
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Nephrectomy
  • Norepinephrine / antagonists & inhibitors*
  • Norepinephrine / pharmacology
  • Pyridines*
  • Rats
  • Rats, Inbred Strains

Substances

  • Antihypertensive Agents
  • Diuretics
  • Pyridines
  • Desoxycorticosterone
  • cicletanine
  • Norepinephrine